KLK13 Activators
KLK13 activators embody a range of chemicals which, directly or indirectly, influence the function or expression of KLK13. KLK13's physiological roles make it responsive to a spectrum of cellular signals. Notably, KLK13 expression can be modulated by hormonal cues. DHT and Estradiol, core components of androgen and estrogen pathways respectively, can directly influence KLK13's expression, highlighting the protein's susceptibility to endocrine signals. Furthermore, the nuanced intricacies of KLK13's presence in the skin places it under the regulatory umbrella of skin differentiation agents such as Retinoic Acid and Bexarotene. These agents, through their interaction with retinoic acid receptors, can influence genes pivotal to skin differentiation processes where KLK13 plays a role.
Moreover, KLK13's association with the kallikrein family makes it a candidate for modulation by pathways intersecting with inflammation, immune responses, and enzymatic activity. Curcumin's influence on the NF-κB pathway provides an avenue for modulating KLK13 expression given the protein's link with inflammatory processes. On the other hand, the renin-angiotensin system, which has interplay with certain kallikreins, suggests that agents like Captopril can have an indirect effect on KLK13. Another noteworthy point is the enzyme modulatory role of Zinc, which, due to KLK13's enzymatic nature, offers another pathway of influence. Lastly, agents like Sodium Butyrate and A23187 further highlight the diverse chemical landscape that can converge on KLK13, either through chromatin remodeling or by affecting intracellular calcium dynamics. The landscape of KLK13 activators, thus, represents a diverse chemical constellation, each member of which provides a unique avenue of interaction with KLK13.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estradiol, an estrogen, binds to estrogen receptors. KLK13, being hormonally-regulated, can be influenced by estradiol, which modulates gene expression via estrogen receptor signaling. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a glucocorticoid receptor agonist. Glucocorticoids can modulate the expression of various genes, potentially affecting KLK13, which has shown regulation by steroid hormones. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, the active form of vitamin A, binds to retinoic acid receptors, influencing the transcription of genes in skin differentiation. Since KLK13 is expressed in the skin, retinoic acid can modulate KLK13 expression through this differentiation pathway. | ||||||
Trifluoperazine Dihydrochloride | 440-17-5 | sc-201498 sc-201498A | 1 g 5 g | $57.00 $101.00 | 9 | |
Trifluoperazine, a calmodulin antagonist, can alter calcium signaling in cells. Given that calcium-dependent pathways play a role in the expression of various kallikreins, trifluoperazine can indirectly influence KLK13 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin affects the NF-κB pathway, a key regulator of immune responses and inflammation. Given that kallikreins, including KLK13, can be involved in inflammatory processes, modulating the NF-κB pathway with curcumin can influence KLK13 activity. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
Bexarotene is a retinoid X receptor (RXR) agonist. Activation of RXR can influence skin differentiation processes, potentially affecting KLK13, which is known to be expressed in the skin. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
Captopril inhibits angiotensin-converting enzyme, influencing the renin-angiotensin system. Given that some kallikreins interact with this system, captopril's modulation can indirectly impact KLK13. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc can modulate metalloproteases and other enzymes. Given the enzymatic nature of kallikreins, zinc's role in enzyme modulation can indirectly influence KLK13 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC). As PKC is involved in various cellular signaling pathways, its activation can influence a wide range of proteins, including potential effects on KLK13 via downstream signaling cascades. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate is an HDAC inhibitor. By modifying the chromatin structure and influencing transcriptional activities, it can potentially affect the expression of KLK13. | ||||||